Sanofi India Ltd
About
Sanofi India Limited has been a significant player in the Indian healthcare sector since its establishment in 1956 as Hoechst Fedco Pharma Pvt. Ltd. The company is a subsidiary of the global pharmaceutical giant Sanofi. Sanofi India was founded through a financial and technical collaboration with Farbwerke Hoechst AG, West Germany. The company is headquartered in Mumbai, Maharashtra. Sanofi India is led by Chairman Aditya Narayan. The company operates in key therapeutic areas, including diabetes, cardiology, anti-infectives, thrombosis, consumer healthcare, and the central nervous system.Sanofi India has a presence in over 100 countries and healthcare solutions available in more than 170 nations. The company recently announced the demerger of its consumer healthcare business into a wholly owned subsidiary, Sanofi Consumer Healthcare India Ltd, subject to regulatory and shareholder approvals.
Featured In Fortune India Ranking
Financial Data 2023
Financial Data
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 3227 8.1% | 2985 -14.2% | 3477 18.5% | 2934 -7.2% | 3162 8.3% | 2921 19.6% | 2443 -1.0% | 2468 7.7% | 2292 1.4% | 2259 18.8% | 1902 17.2% | 1623 10.6% | 1467 7.5% | 1364 17.1% | 1165 6.1% | 1098 - |
| Net Operating Income (INR Cr) | 2851 0.00% | 2770 -6.31% | 2957 1.88% | 2902 -5.49% | 3071 10.82% | 2771 12.64% | 2460 3.93% | 2367 7.92% | 2193 10.90% | 1977 9.32% | 1809 14.99% | 1573 20.88% | 1301 19.94% | 1085 11.34% | 974 -2.11% | 995 15.20% |
| Profit (INR Cr) | 603 -2.9% | 621 -34.3% | 944 97.7% | 478 15.3% | 414 8.8% | 381 16.8% | 326 7.2% | 304 -5.4% | 322 22.0% | 264 -0.6% | 265 50.1% | 177 -7.6% | 191 -17.2% | 231 46.6% | 157 -5.3% | 166 - |
| Assets (INR Cr) | 1065 -20.2% | 1335 -42.3% | 2312 4.8% | 2206 -11.6% | 2496 10.1% | 2268 9.4% | 2073 7.0% | 1938 16.2% | 1667 9.8% | 1518 10.6% | 1373 12.2% | 1223 7.6% | 1137 12.1% | 1014 8.8% | 932 12.4% | 829 - |
| Net Worth (INR Cr) | 1015 0.0% | 1276 -42.7% | 2226 5.0% | 2119 -13.2% | 2442 10.1% | 2219 9.5% | 2026 7.6% | 1883 15.8% | 1627 9.7% | 1482 10.9% | 1336 12.0% | 1193 8.0% | 1105 10.3% | 1001 9.1% | 918 12.7% | 815 17.8% |
| Employee Cost (INR Cr) | 371 -8.7% | 406 -6.5% | 434 -5.8% | 461 2.5% | 450 10.6% | 407 10.4% | 369 3.7% | 355 6.6% | 333 15.6% | 288 19.0% | 242 13.3% | 214 21.2% | 176 9.4% | 161 14.3% | 141 21.2% | 116 - |
| Interest Cost (INR Cr) | 2 | 2 | 2 | 2 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 |
| Cash & Bank Balance (INR Cr) | 407 | 1017 | 1550 | 1209 | 1130 | 832 | 730 | 561 | 572 | 469 | 264 | 430 | 234 | 655 | 586 | 497 |
| Total Debt (INR Cr) | 19 | 24 | 25 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Key Financial Ratios
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 18.7% | 20.8% | 27.2% | 16.3% | 13.1% | 13.0% | 13.3% | 12.3% | 14.0% | 11.7% | 14.0% | 10.9% | 13.0% | 16.9% | 13.5% | 15.1% |
| Profit As % Of Assets | 56.6% | 46.5% | 40.9% | 21.7% | 16.6% | 16.8% | 15.7% | 15.7% | 19.3% | 17.4% | 19.3% | 14.4% | 16.8% | 22.8% | 16.9% | 20.1% |
| Profit As % Of Networth | 59.4% | 48.6% | 42.4% | 22.5% | 17.0% | 17.2% | 16.1% | 16.2% | 19.8% | 17.8% | 19.8% | 14.8% | 17.3% | 23.0% | 17.2% | 20.4% |
| Interest Cost to EBITDA % | 0.2% | 0.2% | 0.2% | 0.3% | 0.1% | 0.1% | 0.2% | 0.4% | 0.1% | 0.1% | 0.1% | 0.5% | 0.3% | 4.5% | 0.1% | 0.2% |
| Debt to Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - | - | - | - |
| RONW | 59.4% | 30.1% | 26.8% | 20.9% | 19.4% | 17.9% | 16.7% | 17.3% | 17.1% | 14.0% | 21.0% | 15.4% | 18.2% | 16.2% | 18.2% | 22.1% |
| ROCE | 79.6% | 40.3% | 33.8% | 28.9% | 27.8% | 28.1% | 25.7% | 26.8% | 25.0% | 21.3% | 30.2% | 22.5% | 26.8% | 24.7% | 27.9% | 34.5% |